BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 17555752)

  • 1. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
    Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
    Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kappaB and mitogen-activated protein kinase pathways.
    Yamauchi N; Harada T; Taniguchi F; Yoshida S; Iwabe T; Terakawa N
    Fertil Steril; 2004 Oct; 82 Suppl 3():1023-8. PubMed ID: 15474068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-10 attenuates TNF-alpha-induced interleukin-6 production in endometriotic stromal cells.
    Tagashira Y; Taniguchi F; Harada T; Ikeda A; Watanabe A; Terakawa N
    Fertil Steril; 2009 May; 91(5 Suppl):2185-92. PubMed ID: 18684450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide-promoted proliferation of endometriotic stromal cells via induction of tumor necrosis factor alpha and interleukin-8 expression.
    Iba Y; Harada T; Horie S; Deura I; Iwabe T; Terakawa N
    Fertil Steril; 2004 Oct; 82 Suppl 3():1036-42. PubMed ID: 15474070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells.
    Horie S; Harada T; Mitsunari M; Taniguchi F; Iwabe T; Terakawa N
    Fertil Steril; 2005 May; 83(5):1530-5. PubMed ID: 15866594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats.
    Lahiri S; Sen T; Palit G
    Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
    Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
    Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parthenolide reduces cell proliferation and prostaglandin E2 [corrected] in human endometriotic stromal cells and inhibits development of endometriosis in the murine model.
    Takai E; Taniguchi F; Nakamura K; Uegaki T; Iwabe T; Harada T
    Fertil Steril; 2013 Oct; 100(4):1170-8. PubMed ID: 23876538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of nuclear factor-kappaB on peroxisome proliferator activated receptor gamma expression in Ana-1 cells].
    Xiao B; Wang JC; Wang GS; Ji FY; Xu J
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):3-7. PubMed ID: 19141181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
    Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
    J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
    Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
    Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human chorionic gonadotrophin attenuates NF-kappaB activation and cytokine expression of endometriotic stromal cells.
    Huber AV; Saleh L; Prast J; Haslinger P; Knöfler M
    Mol Hum Reprod; 2007 Aug; 13(8):595-604. PubMed ID: 17525069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes.
    Ji JD; Cheon H; Jun JB; Choi SJ; Kim YR; Lee YH; Kim TH; Chae IJ; Song GG; Yoo DH; Kim SY; Sohn J
    J Autoimmun; 2001 Nov; 17(3):215-21. PubMed ID: 11712859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.
    Tahan F; Jazrawi E; Moodley T; Rovati GE; Adcock IM
    Clin Exp Allergy; 2008 May; 38(5):805-11. PubMed ID: 18325031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation.
    Mehta JL; Hu B; Chen J; Li D
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2203-8. PubMed ID: 12958047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
    Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
    Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
    Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
    Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.